Literature DB >> 20601806

Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.

Soonmo Peter Kang1, Muhammad Wasif Saif.   

Abstract

Diabetes mellitus and its related factors such as hyperinsulinemia have been linked to various cancer risks and outcomes. Previous research has offered inconsistent results in terms of relationship between diabetes and pancreatic cancers. Establishing clear association between these two entities may guide us in improving clinical outcomes of pancreatic cancer patients. Two abstracts that examined the association between diabetes mellitus and pancreatic cancer are updated in this paper. Herein, the authors report updated information from the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in association between pancreatic cancer and diabetes mellitus. The present paper illustrates insufficient knowledge base to draw a conclusion in this topic. However, validation and understanding of the association could have significant clinical implications with respect to cancer prevention, early detection, and treatment. As such, further investigations are warranted to explore the link diabetes and pancreatic cancers.

Entities:  

Mesh:

Year:  2010        PMID: 20601806

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  9 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

2.  Diabetes and pancreatic cancer.

Authors:  Donghui Li
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 3.  Prognostic factors related with survival in patients with pancreatic adenocarcinoma.

Authors:  Ahmet Bilici
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

4.  Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.

Authors:  Donghui Li; Yixiang Mao; Ping Chang; Chang Liu; Manal M Hassan; Saiching J Yeung; James L Abbruzzese
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

5.  Diabetes Type 2 and Pancreatic Cancer: A History Unfolding.

Authors:  Andre De Souza; Khawaja Irfan; Faisal Masud; Muhammad Wasif Saif
Journal:  JOP       Date:  2016-03

Review 6.  Advances in pancreatic cancer research: moving towards early detection.

Authors:  Xiang-Yi He; Yao-Zong Yuan
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

7.  Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study.

Authors:  Gianpaolo Balzano; Erica Dugnani; Alessandra Gandolfi; Marina Scavini; Valentina Pasquale; Francesca Aleotti; Daniela Liberati; Gaetano Di Terlizzi; Giovanna Petrella; Michele Reni; Claudio Doglioni; Emanuele Bosi; Massimo Falconi; Lorenzo Piemonti
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

8.  Association between fasting blood glucose levels at admission and overall survival of patients with pancreatic cancer.

Authors:  Mingming Zhang; Xiaoru Hu; Ye Kang; Wanfeng Xu; Xianghong Yang
Journal:  BMC Cancer       Date:  2021-02-06       Impact factor: 4.430

9.  Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells.

Authors:  Frederico Alisson-Silva; Leonardo Freire-de-Lima; Joana L Donadio; Miguel C Lucena; Luciana Penha; Julliana N Sá-Diniz; Wagner B Dias; Adriane R Todeschini
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.